קם-רהו די

Land: Israel

Språk: hebreiska

Källa: Ministry of Health

Aktiva substanser:

ANTI-D IMMUNOGLOBULINS

Tillgänglig från:

KAMADA LTD, ISRAEL

ATC-kod:

J06BB01

Läkemedelsform:

תמיסה להזרקה

Sammansättning:

ANTI-D IMMUNOGLOBULINS 150 MCG / 1 ML

Administreringssätt:

תוך-ורידי

Receptbelagda typ:

מרשם נדרש

Tillverkad av:

KAMADA LTD, ISRAEL

Terapeutisk grupp:

ANTI-D (RH) IMMUNOGLOBULIN

Terapiområde:

ANTI-D (RH) IMMUNOGLOBULIN

Terapeutiska indikationer:

Suppression of Rh immunization in non-sensitized Rho(D) negative women delivering an Rh positive baby, or when the baby's Rh type is unknown. Suppression of Rh immunization after spontaneous or induced abortions, threatened abortion associated with maternal bleeding amniocentesis, chorionic villus sampling ruptured tubal pregnancy, and significant abdominal trauma. KAM-Rho should be given within 72 hours of event. Immune thrombocytopenic purpura (ITP): Rho (d)-positive adults with chronic ITP, children with chronic or acute ITP, and patients with Thrombocytopenia secondary to HIV infection in clinical situations requiring an increase in platelet count to prevent excessive hemorrhage.

Tillstånd datum:

2013-03-31